Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- A01091-1 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-PI3 Kinase p110 beta/PIK3CB Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for PI 3 KINASE P110 BETA/PIK3CB detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. PI 3 KINASE P110 BETA/PIK3CB information: Molecular Weight: 122762 MW; Subcellular Localization: Cytoplasm . Nucleus . Interaction with PIK3R2 is required for nuclear localization and export; Tissue Specificity: Expressed ubiquitously.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references CXCR4 protects bone marrow-derived endothelial progenitor cells against hypoxia through the PI3K/Akt signaling pathway.
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Liu ZY, Yang QX, Cao Y, Pan HW, Rong JJ, Ling J, Tang Y, He J, Wang CL, Peng X, Zou QC, Zhang L, Zheng J, Wang J, Zhang Y, Peng JQ, Xiong LB, Liu F, Ying ZH, Zheng ZF, Zhang BL
Experimental and therapeutic medicine 2021 Nov;22(5):1200
Experimental and therapeutic medicine 2021 Nov;22(5):1200
MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Zhang Z, Zhang L, Wang B, Wei R, Wang Y, Wan J, Zhang C, Zhao L, Zhu X, Zhang Y, Chu C, Guo Q, Yin X, Li X
Cancer letters 2020 Jan 28;469:54-67
Cancer letters 2020 Jan 28;469:54-67
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- IHC analysis of PIK3CB using anti- PIK3CB antibody (A01091-1). PIK3CB was detected in paraffin-embedded section of human intestinal cancer tissues. Heat mediated antigen retrieval was performed in citrate buffer (pH6, epitope retrieval solution) for 20 mins. The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 1μg/ml rabbit anti- PIK3CB Antibody (A01091-1) overnight at 4°C. Biotinylated goat anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using Strepavidin-Biotin-Complex (SABC)(Catalog # SA1022) with DAB as the chromogen.
- Additional image
